Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03)

被引:0
|
作者
Jens Jakob
Anna Simeonova
Bernd Kasper
Ulrich Ronellenfitsch
Geraldine Rauch
Frederik Wenz
Peter Hohenberger
机构
[1] University Medical Center and Medical Faculty Mannheim,Division of Surgical, Oncology and Thoracic Surgery, Department of Surgery
[2] University of Heidelberg,Department of Radiation Oncology
[3] University Medical Center Mannheim,Sarcoma Unit, Interdisciplinary Tumor Center Mannheim
[4] University of Heidelberg,Division of Surgical, Oncology and Thoracic Surgery, Department of Surgery
[5] Mannheim University Medical Center,Institute of Medical Biometry and Informatics
[6] University of Heidelberg,Department of Radiation Oncology
[7] University Medical Center Mannheim,undefined
[8] University of Heidelberg,undefined
[9] University of Heidelberg,undefined
[10] University Medical Center and Medical Faculty Mannheim,undefined
[11] University of Heidelberg,undefined
来源
关键词
Sunitinib; Soft Tissue Sarcoma; Dose Limit Toxicity; Intensity Modulate Radiation Therapy; Clinical Target Volume;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: A phase I-II study from the Italian Sarcoma Group
    Gronchi, Alessandro
    De Paoli, Antonino
    Dani, Carla
    Merlo, Domenico Franco
    Quagliuolo, Vittorio
    Grignani, Giovanni
    Bertola, Giulio
    Navarria, Piera
    Sangalli, Claudia
    Buonadonna, Angela
    De Sanctis, Rita
    Sanfilippo, Roberta
    Dei Tos, Angelo Paolo
    Stacchiotti, Silvia
    Giorello, Laura
    Fiore, Marco
    Bruzzi, Paolo
    Casali, Paolo Giovanni
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (04) : 784 - 792
  • [32] IMMUNOSARC: A collaborative Spanish (GEIS) and Italian (ISG) Sarcoma Groups phase I/II trial of sunitinib plus nivolumab in selected bone and soft tissue sarcoma subtypes-Results of the phase I part.
    Broto, Javier Martin
    Hindi, Nadia
    Redondo, Andres
    Martinez-Trufero, Javier
    Stacchiotti, Silvia
    Palmerini, Emanuela
    Alava, Enrique
    Silva Moura, David
    Perez Vega, Herminia
    Otero, Irene
    Ledesma, Patricio
    Marchesi, Emanuela
    Lopez-Martin, Jose A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] The IMRiS Trial: A Phase 2 Study of Intensity Modulated Radiation Therapy in Extremity Soft Tissue Sarcoma
    Seddon, Beatrice
    Le Grange, Franel
    Simoes, Rita
    Stacey, Chris
    Shelly, Shumona
    Forsyth, Sharon
    White, Laura
    Candish, Charles
    Dickinson, Peter
    Miah, Aisha
    Moinuddin, Syed Ali
    Wylie, James
    Lopes, Andre
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (04): : 978 - 989
  • [34] Supportive intervention to improve quality of life (QoL) for patients with soft tissue sarcoma (STS) undergoing palliative treatment: a multicenter, clusterrandomized, controlled trial within the German Interdisciplinary Sarcoma group
    Hentschel, L.
    Richter, S.
    Kopp, H. -G.
    Kasper, B.
    Kunitz, A.
    Gruenwald, V.
    Kessler, T.
    Chemnitz, J. M.
    Pelzer, U.
    Schuler, U.
    Freitag, J.
    Schilling, A.
    Hornemann, B.
    Arndt, K.
    Ehninger, G.
    Bornhaeuser, M.
    Schuler, M. K.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 137 - 137
  • [35] Vorinostat in refractory soft tissue sarcomas - Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO)
    Schmitt, Thomas
    Mayer-Steinacker, Regine
    Mayer, Frank
    Gruenwald, Viktor
    Schuette, Jochen
    Hartmann, Joerg T.
    Kasper, Bernd
    Huesing, Johannes
    Hajda, Jacek
    Ottawa, Gregor
    Mechtersheimer, Gunhild
    Mikus, Gerd
    Burhenne, Juergen
    Lehmann, Lorenz
    Heilig, Christoph E.
    Ho, Anthony D.
    Egerer, Gerlinde
    EUROPEAN JOURNAL OF CANCER, 2016, 64 : 74 - 82
  • [36] A Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma
    Roeder, Falk
    Schulz-Ertner, Daniela
    Nikoghosyan, Anna V.
    Huber, Peter E.
    Edler, Lutz
    Habl, Gregor
    Krempien, Robert
    Oertel, Susanne
    Saleh-Ebrahimi, Ladan
    Hensley, Frank W.
    Buechler, Markus W.
    Debus, Juergen
    Koch, Moritz
    Weitz, Juergen
    Bischof, Marc
    BMC CANCER, 2012, 12
  • [37] A Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma
    Falk Roeder
    Daniela Schulz-Ertner
    Anna V Nikoghosyan
    Peter E Huber
    Lutz Edler
    Gregor Habl
    Robert Krempien
    Susanne Oertel
    Ladan Saleh-Ebrahimi
    Frank W Hensley
    Markus W Buechler
    Juergen Debus
    Moritz Koch
    Juergen Weitz
    Marc Bischof
    BMC Cancer, 12
  • [38] Phase II clinical trial evaluating the activity and tolerability of pazopanib in patients (pts) with advanced and/or metastatic liposarcoma (LPS): A joint Spanish Sarcoma Group (GEIS) and German Interdisciplinary Sarcoma Group (GISG) Study NCT01692496.
    Valverde, Claudia Maria
    Broto, Javier Martin
    Lopez-Martin, Jose A.
    Romagosa, Cleofe
    Marquez, Maria Pilar Sancho
    Carrasco, Juan Antonio
    Poveda, Andres
    Bauer, Sebastian
    Martinez-Trufero, Javier
    Cruz, Josefina
    Reichard, Peter
    Fra, Pablo Luna
    Gruenwald, Viktor
    Persiva, Oscar
    Porres, Diego Varona
    Kasper, Bernd
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Which patients with pre-treated locally advanced or metastatic sarcoma benefit most from trabectedin treatment: First results of a retrospective study of the German Interdisciplinary Sarcoma Group (GISG-14-ReTraSarc).
    Pink, Daniel
    Richter, Adrian
    Andreou, Dimosthenis
    Richter, Stephan
    Florcken, Anne
    Deinzer, Christoph
    Kasper, Bernd
    Egerer, Gerlinde
    Ivanyi, Philipp
    Tuchscherer, Armin
    Kessler, Torsten
    Schuler, Markus
    Schmidt, Christian
    Bahr, Jeannette
    Ittermann, Till
    Reichardt, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] RTOG 0330: A pilot phase II study of preoperative radiation therapy/thalidomide for low-grade primary soft tissue sarcoma or preoperative MAID/thalidomide/radiation therapy for high/intermediate grade primary soft tissue sarcoma of the extremity or body wall
    Kane, J. M., III
    Harris, J.
    Kraybill, W. G.
    Harmon, D. C.
    Ettinger, D. S.
    Lucas, D. R.
    DeLaney, T. F.
    Wang, D.
    Curran, W. J., Jr.
    Eisenberg, B. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)